Cranbrook Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8K | Hold |
576
| – | – | 0.01% | 200 |
|
|
2025
Q1 | $46.7K | Hold |
576
| – | – | 0.01% | 190 |
|
|
2024
Q4 | $51.9K | Sell |
576
-201
| -26% | -$18.1K | 0.01% | 187 |
|
|
2024
Q3 | $76.8K | Hold |
777
| – | – | 0.02% | 163 |
|
|
2024
Q2 | $72K | Hold |
777
| – | – | 0.02% | 164 |
|
|
2024
Q1 | $73.7K | Hold |
777
| – | – | 0.02% | 141 |
|
|
2023
Q4 | $69.4K | Hold |
777
| – | – | 0.02% | 143 |
|
|
2023
Q3 | $56.7K | Hold |
777
| – | – | 0.02% | 142 |
|
|
2023
Q2 | $64.6K | Hold |
777
| – | – | 0.02% | 140 |
|
|
2023
Q1 | $59.2K | Hold |
777
| – | – | 0.02% | 143 |
|
|
2022
Q4 | $64.5K | Hold |
777
| – | – | 0.02% | 141 |
|
|
2022
Q3 | $62K | Hold |
777
| – | – | 0.02% | 155 |
|
|
2022
Q2 | $58K | Hold |
777
| – | – | 0.01% | 160 |
|
|
2022
Q1 | $70K | Hold |
777
| – | – | 0.02% | 155 |
|
|
2021
Q4 | $87K | Hold |
777
| – | – | 0.02% | 144 |
|
|
2021
Q3 | $98K | Hold |
777
| – | – | 0.02% | 136 |
|
|
2021
Q2 | $105K | Hold |
777
| – | – | 0.02% | 129 |
|
|
2021
Q1 | $105K | Hold |
777
| – | – | 0.03% | 130 |
|
|
2020
Q4 | $109K | Buy |
777
+414
| +114% | +$58.1K | 0.03% | 122 |
|
|
2020
Q3 | $40K | Hold |
363
| – | – | 0.01% | 152 |
|
|
2020
Q2 | $41K | Hold |
363
| – | – | 0.01% | 149 |
|
|
2020
Q1 | $28K | Buy |
363
+162
| +81% | +$12.5K | 0.01% | 150 |
|
|
2019
Q4 | $19K | Sell |
201
-158
| -44% | -$14.9K | 0.01% | 181 |
|
|
2019
Q3 | $27K | Hold |
359
| – | – | 0.01% | 160 |
|
|
2019
Q2 | $31K | Hold |
359
| – | – | 0.01% | 155 |
|
|
2019
Q1 | $33K | Hold |
359
| – | – | 0.01% | 152 |
|
|
2018
Q4 | $26K | Buy |
+359
| New | +$26K | 0.01% | 155 |
|